Effectiveness of treatment of tralokinumab in treatment of atopic dermatitis in adolescents

被引:0
|
作者
Tahira, Sameen [1 ]
Mushtaq, Fiza [1 ]
机构
[1] Allama Iqbal Med Coll, Lahore, Pakistan
关键词
D O I
10.47391/JPMA.9995
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:2333 / 2333
页数:1
相关论文
共 50 条
  • [21] Tralokinumab treatment for patients with moderate-to-severe atopic dermatitis in daily practice
    Schloesser, Anne R.
    Shareef, Madena
    Olydam, Jill
    Nijsten, Tamar E. C.
    Hijnen, Dirk Jan
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2023, 48 (05) : 510 - 517
  • [22] Therapeutic Potential of Tralokinumab in the Treatment of Atopic Dermatitis: A Review on the Emerging Clinical Data
    Kelly, Katherine A.
    Perche, Patrick O.
    Feldman, Steven R.
    CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY, 2022, 15 : 1037 - 1043
  • [23] Safety of tralokinumab in atopic dermatitis
    Simpson, Rosalind C.
    BRITISH JOURNAL OF DERMATOLOGY, 2023, 188 (04) : E25 - E26
  • [24] Successful treatment with tralokinumab in patients with atopic dermatitis and dupilumab-induced psoriasis
    Quattrini, L.
    Caldarola, G.
    Falco, G. M.
    Pinto, L. M.
    Peris, K.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2023, 37 (12) : E1432 - E1434
  • [25] Treatment of atopic dermatitis in children and adolescents.
    Beaulieu, P
    Pradalier, A
    REVUE FRANCAISE D ALLERGOLOGIE ET D IMMUNOLOGIE CLINIQUE, 1996, 36 (01): : 9 - 17
  • [26] Methotrexate for treatment of atopic dermatitis in children and adolescents
    Deo, Maneka
    Yung, Anthony
    Hill, Sarah
    Rademaker, Marius
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2014, 53 (08) : 1037 - 1041
  • [27] Proactive treatment and clinical effectiveness in atopic dermatitisin atopic dermatitis
    Gul, Ulker
    TURKDERM-TURKISH ARCHIVES OF DERMATOLOGY AND VENEROLOGY, 2018, 52 (03): : 106 - 107
  • [28] Long-term treatment with tralokinumab normalizes the molecular gene signature of atopic dermatitis
    Guttman-Yassky, E.
    Pavel, A.
    Kabashima, K.
    Staumont-Salle, D.
    Eyerich, K.
    Nahm, W.
    Pauser, S.
    Da Rosa, J. C.
    Roepke, M.
    Amoudruz, P.
    Blauvelt, A.
    Reich, K.
    EXPERIMENTAL DERMATOLOGY, 2021, 30 : 27 - 28
  • [29] Long-term treatment with tralokinumab normalizes the molecular gene signature of atopic dermatitis
    Guttman-Yassky, E.
    Pavel, A.
    Kabashima, K.
    Staumont-Salle, D.
    Eyerich, K.
    Nahm, W.
    Pauser, S.
    Da Rosa, J. Correa
    Roepke, M.
    Amoudruz, P.
    Schneider, S.
    Blauvelt, A.
    Reich, K.
    BRITISH JOURNAL OF DERMATOLOGY, 2022, 186 (04) : E146 - E147
  • [30] Long-term treatment with tralokinumab normalizes the molecular gene signature of atopic dermatitis
    Guttman-Yassky, E.
    Pavel, A.
    Kabashima, K.
    Staumont-Salle, D.
    Eyerich, K.
    Nahm, W.
    Pauser, S.
    Da Rosa, J. Correa
    Ropke, M.
    Amoudruz, P.
    Blauvelt, A.
    Reich, K.
    ALLERGY AND ASTHMA PROCEEDINGS, 2022, 43 (06) : 567 - 567